查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1291422

放射性皮炎市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Radiodermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

市場概述：

全球放射性皮炎市場規模在2022年達到4.819億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到5.979億美元，在2023-2028年期間表現出3.5%的成長率（CAGR）。

放射性皮炎，或稱輻射性皮炎，是指由於用於治療癌症的放射療法而引起的一種皮膚病。它通常作為癌症治療期間或介入放射治療後的副作用發生在乳房、肺部、皮膚、頸部、頭部或會陰部癌症患者身上，因為皮膚是靶區的一部分。治療放射性皮炎的一些常用產品包括局部抗生素、皮質類固醇、親水乳膏、水凝膠和水膠體敷料、矽塗層敷料、銀葉敷料、口服鎮痛劑和消炎劑。近年來，放射性皮炎的治療已經得到了重視，因為它有助於減少不適，盡量減少疼痛，防止正在進行的治療中斷，同時提高病人的整體生活品質。

放射性皮炎的市場趨勢：

癌症的廣泛流行和擴大採用放射療法作為治療選擇，是推動市場成長的主要因素。除此以外，全球範圍內老年人口的增加和應對放療的不良副作用的需求不斷增加，都增強了對放射性皮炎治療的需求。此外，許多管理和非管理機構正在採取有利的計劃，傳播有關現有放射性皮炎治療和管理產品的意識。這一點，再加上公共和私人投資在生命科學領域正在進行的研究和開發（R&D）活動中的增加，正在催化市場的成長。此外，領先的企業正專注於開發創新的產品變體，以擴大其產品組合併獲得競爭優勢。此外，不斷增加的臨床試驗、有利的政府政策、不斷增加的消費能力、不斷改善的醫療基礎設施和容易獲得的非專利藥品，是創造積極市場前景的其他一些因素。

本報告回答的關鍵問題：

  • 2022年全球放射性皮炎市場的規模是多少？
  • 2023-2028年，全球放射性皮炎市場的預期成長率是多少？
  • COVID-19對全球放射性皮炎市場的影響是什麼？
  • 推動全球放射性皮炎市場的關鍵因素是什麼？
  • 基於產品的全球放射性皮炎市場的詳細情形是什麼？
  • 基於配銷通路的全球放射性皮炎市場的詳細情形如何？
  • 全球放射性皮炎市場的主要地區有哪些？
  • 誰是全球放射性皮炎市場的主要參與者/公司？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球放射性皮炎市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按產品分類的市場

  • 專題
    • 市場趨勢
    • 關鍵領域
      • 皮質類固醇
      • 親水性藥膏
      • 抗生素
      • 其他
    • 市場預測
  • 口服
    • 市場趨勢
    • 市場預測
  • 敷料
    • 市場趨勢
    • 關鍵領域
      • 水凝膠和水膠體敷料
      • 無刺阻隔膜
      • 蜂蜜浸泡的紗布
      • 矽膠塗層敷料
      • 其他
    • 市場預測

第7章：按配銷通路分類的市場

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥店
    • 市場趨勢
    • 市場預測
  • 網上藥店
    • 市場趨勢
    • 市場預測

第8章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第九章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十章：價值鏈分析

第十一章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十二章：價格分析

第十三章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • 3M Company
    • Bausch Health Companies Inc.
    • Bayer AG
    • BMG PHARMA SpA
    • Charles River Laboratories International Inc.
    • ConvaTec Group plc
    • Helsinn Healthcare SA
    • ICON plc
    • Integra LifeSciences
    • Molnlycke Health Care AB
    • Stratpharma AG
Product Code: SR112023A5638

Market Overview:

The global radiodermatitis market size reached US$ 481.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 597.9 Million by 2028, exhibiting a growth rate (CAGR) of 3.5% during 2023-2028.

Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer. It generally occurs as a side effect during cancer treatment or after interventional radiology in patients with cancers of the breast, lungs, skin, neck, head or perineum region where the skin is part of the target field. Some of the commonly used products to treat radiodermatitis include topical antibiotics, corticosteroids, hydrophilic creams, hydrogel and hydrocolloid dressings, silicone-coated dressings, silver-leaf dressings, oral analgesics, and anti-inflammatory agents. In recent years, radiodermatitis treatment has gained traction as it helps reduce discomfort, minimize pain and prevent interruption in ongoing therapy while improving the overall quality of the patient's life. 

Radiodermatitis Market Trends:

The widespread prevalence of cancer and the rising adoption of radiation therapy as a treatment option represent the primary factors driving the market growth. Besides this, the increasing geriatric population across the globe and the growing need to counter the adverse side effects of radiation therapy are augmenting the demand for radiodermatitis treatment. Additionally, numerous governing and non-governing agencies are taking favorable initiatives to spread awareness regarding the available radiodermatitis treatment and management products. This, in confluence with the rising public and private investments in the ongoing research and development (R&D) activities in the field of life sciences, is catalyzing the market growth. Furthermore, the leading players are focusing on developing innovative product variants to expand their product portfolio and gain a competitive edge. Moreover, the rising number of clinical trials, favorable government policies, increasing consumer expenditure capacities, improving healthcare infrastructure and easy availability of generic drugs are some of the other factors creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global radiodermatitis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and distribution channel.

Breakup by Product:

  • Topical
    • Corticosteroids
    • Hydrophilic Creams
    • Antibiotics
    • Others
  • Oral
  • Dressings
    • Hydrogel and Hydrocolloid Dressings
    • No Sting Barrier Film
    • Honey Impregnated Gauze
    • Silicone Coated Dressings
    • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Bausch Health Companies Inc., Bayer AG, BMG PHARMA S.p.A., Charles River Laboratories International Inc., ConvaTec Group plc, Helsinn Healthcare SA, ICON plc, Integra LifeSciences, Molnlycke Health Care AB and Stratpharma AG.

Key Questions Answered in This Report:

  • What was the size of the global radiodermatitis market in 2022?
  • What is the expected growth rate of the global radiodermatitis market during 2023-2028?
  • What has been the impact of COVID-19 on the global radiodermatitis market?
  • What are the key factors driving the global radiodermatitis market?
  • What is the breakup of the global radiodermatitis market based on the product?
  • What is the breakup of the global radiodermatitis market based on the distribution channel?
  • What are the key regions in the global radiodermatitis market?
  • Who are the key players/companies in the global radiodermatitis market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Radiodermatitis Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product

  • 6.1  Topical
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Corticosteroids
      • 6.1.2.2 Hydrophilic Creams
      • 6.1.2.3 Antibiotics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2  Oral
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Dressings
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hydrogel and Hydrocolloid Dressings
      • 6.3.2.2 No Sting Barrier Film
      • 6.3.2.3 Honey Impregnated Gauze
      • 6.3.2.4 Silicone Coated Dressings
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7   Market Breakup by Distribution Channel

  • 7.1  Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Region

  • 8.1  North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2  Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3  Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4  Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5  Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9   SWOT Analysis

  • 9.1  Overview
  • 9.2  Strengths
  • 9.3  Weaknesses
  • 9.4  Opportunities
  • 9.5  Threats

10  Value Chain Analysis

11  Porters Five Forces Analysis

  • 11.1  Overview
  • 11.2  Bargaining Power of Buyers
  • 11.3  Bargaining Power of Suppliers
  • 11.4  Degree of Competition
  • 11.5  Threat of New Entrants
  • 11.6  Threat of Substitutes

12  Price Analysis

13  Competitive Landscape

  • 13.1  Market Structure
  • 13.2  Key Players
  • 13.3  Profiles of Key Players
    • 13.3.1  3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2  Bausch Health Companies Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3  Bayer AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4  BMG PHARMA S.p.A.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5  Charles River Laboratories International Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6  ConvaTec Group plc
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7  Helsinn Healthcare SA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8  ICON plc
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9  Integra LifeSciences
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10  Molnlycke Health Care AB
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis
    • 13.3.11  Stratpharma AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Radiodermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Radiodermatitis Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Radiodermatitis Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Radiodermatitis Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Radiodermatitis Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Radiodermatitis (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Radiodermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Radiodermatitis (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Radiodermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Radiodermatitis (Dressings) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Radiodermatitis (Dressings) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Radiodermatitis (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Radiodermatitis (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Radiodermatitis (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Radiodermatitis (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Radiodermatitis (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Radiodermatitis (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: North America: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: North America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: United States: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: United States: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Canada: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Canada: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Asia-Pacific: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Asia-Pacific: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: China: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: China: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Japan: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Japan: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: India: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: India: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: South Korea: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: South Korea: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Australia: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Australia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Indonesia: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Indonesia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Others: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Europe: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Europe: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Germany: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Germany: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: France: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: France: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United Kingdom: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United Kingdom: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Italy: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Italy: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Spain: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Spain: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Russia: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Russia: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Latin America: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Latin America: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Brazil: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Brazil: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Mexico: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Mexico: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Radiodermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Middle East and Africa: Radiodermatitis Market: Breakup by Country (in %), 2022
  • Figure 67: Middle East and Africa: Radiodermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Global: Radiodermatitis Industry: SWOT Analysis
  • Figure 69: Global: Radiodermatitis Industry: Value Chain Analysis
  • Figure 70: Global: Radiodermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiodermatitis Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Radiodermatitis Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Radiodermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Radiodermatitis Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Radiodermatitis Market: Competitive Structure
  • Table 6: Global: Radiodermatitis Market: Key Players